TRAMETINIB

TRAMETINIB was reported 24319 times

TRAMETINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BRAF V600E MUTATION POSITIVE 28 0.4590
1 ANAPLASTIC THYROID CANCER 44 0.3636
2 GANGLIOGLIOMA 12 0.2500
3 METASTATIC MALIGNANT MELANOMA 491 0.2135
4 BRAF GENE MUTATION 17 0.1889
5 JEJUNAL ULCER PERFORATION 8 0.1739
6 MALIGNANT MESENTERIC NEOPLASM 10 0.1316
7 OPTIC GLIOMA 13 0.1313
8 ASTROCYTOMA, LOW GRADE 22 0.1294
9 MELANOMA RECURRENT 54 0.1283
10 HISTIOCYTIC SARCOMA 9 0.1154
11 SEROUS RETINOPATHY 12 0.1143
12 VOGT-KOYANAGI-HARADA DISEASE 25 0.1136
13 NEUROFIBROSARCOMA 11 0.1068
14 PANNICULITIS LOBULAR 9 0.1011
15 GLIOMA 49 0.0762
16 ASTROCYTOMA 27 0.0684
17 BRAIN STEM GLIOMA 10 0.0658
18 MALIGNANT MELANOMA STAGE III 13 0.0640
19 SEROUS RETINAL DETACHMENT 50 0.0597
20 INTESTINAL METASTASIS 21 0.0579
21 LUNG ADENOCARCINOMA STAGE IV 22 0.0577
22 PANNICULITIS 132 0.0545
23 HAEMANGIOMA OF BONE 10 0.0524
24 METASTASES TO ABDOMINAL WALL 10 0.0503
25 ACUTE POLYNEUROPATHY 14 0.0490
26 ANAPLASTIC ASTROCYTOMA 8 0.0485
27 METASTASES TO STOMACH 19 0.0485
28 SARCOID-LIKE REACTION 12 0.0465
29 NON-SMALL CELL LUNG CANCER RECURRENT 13 0.0459
30 LEUKODERMA 8 0.0402
31 METASTASES TO HEART 12 0.0397
32 DETACHMENT OF RETINAL PIGMENT EPITHELIUM 35 0.0393
33 METASTASES TO SPLEEN 16 0.0387
34 METASTASES TO CENTRAL NERVOUS SYSTEM 493 0.0382
35 CHORIORETINOPATHY 51 0.0358
36 MALIGNANT MELANOMA 435 0.0324
37 SMALL CELL CARCINOMA 11 0.0320
38 METASTASES TO THE MEDIASTINUM 13 0.0316
39 PROCALCITONIN INCREASED 37 0.0315
40 CREATINE KINASE INCREASED 24 0.0312
41 METASTASES TO MENINGES 70 0.0308
42 DERMATITIS ACNEIFORM 187 0.0307
43 METASTASES TO SKIN 30 0.0290
44 NON-SMALL CELL LUNG CANCER STAGE IV 10 0.0274
45 URETERAL DISORDER 11 0.0268
46 METASTASES TO ADRENALS 24 0.0260
47 CUTANEOUS SARCOIDOSIS 11 0.0255
48 PARONYCHIA 111 0.0252
49 TUMOUR INVASION 12 0.0246
50 SKIN TOXICITY 138 0.0244
51 AUTOIMMUNE COLITIS 15 0.0233
52 METASTASES TO PERITONEUM 56 0.0222
53 OCULAR TOXICITY 24 0.0217
54 ERYTHEMA NODOSUM 72 0.0205
55 NON-SMALL CELL LUNG CANCER METASTATIC 18 0.0205
56 MALIGNANT NEOPLASM PROGRESSION 2070 0.0202
57 OVARIAN CANCER METASTATIC 17 0.0200
58 HYPERPYREXIA 78 0.0184
59 XEROSIS 22 0.0178
60 UVEITIS 239 0.0176
61 HILAR LYMPHADENOPATHY 15 0.0170
62 GRANULOMATOUS LIVER DISEASE 12 0.0170
63 PERITONEAL DISORDER 11 0.0170
64 EJECTION FRACTION DECREASED 258 0.0166
65 DEMYELINATING POLYNEUROPATHY 17 0.0165
66 NON-SMALL CELL LUNG CANCER 79 0.0165
67 ABDOMINAL LYMPHADENOPATHY 14 0.0161
68 ACQUIRED GENE MUTATION 21 0.0160
69 METASTASIS 110 0.0154
70 SECOND PRIMARY MALIGNANCY 123 0.0148
71 METASTASES TO LYMPH NODES 99 0.0147
72 KERATOACANTHOMA 10 0.0146
73 BRAIN CANCER METASTATIC 10 0.0145
74 ANGULAR CHEILITIS 10 0.0145
75 OVARIAN CANCER RECURRENT 23 0.0143
76 METASTASES TO PLEURA 15 0.0143
77 METASTASES TO LUNG 164 0.0142
78 IRIDOCYCLITIS 42 0.0133
79 BRAIN NEOPLASM 122 0.0133
80 CENTRAL SEROUS CHORIORETINOPATHY 9 0.0132
81 CATARACT SUBCAPSULAR 8 0.0131
82 HYPOPHYSITIS 26 0.0129
83 INTRACRANIAL MASS 12 0.0127
84 ILEAL PERFORATION 8 0.0121
85 GASTROINTESTINAL WALL THICKENING 18 0.0120
86 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 90 0.0120
87 AMYLASE INCREASED 44 0.0119
88 PYREXIA 4116 0.0119
89 METASTATIC NEOPLASM 50 0.0116
90 RETINOPATHY 42 0.0112
91 CHILLS 1303 0.0111
92 PSEUDOMONAS TEST POSITIVE 9 0.0110
93 BLOOD CREATINE PHOSPHOKINASE INCREASED 315 0.0109
94 IMMUNE-MEDIATED HEPATITIS 22 0.0108
95 PRODUCT TEMPERATURE EXCURSION ISSUE 55 0.0107
96 RECURRENT CANCER 43 0.0105
97 TUMOUR HAEMORRHAGE 30 0.0105
98 LUNG ADENOCARCINOMA 31 0.0103
99 GOUTY ARTHRITIS 8 0.0100
100 ERYSIPELAS 48 0.0095
101 ADRENAL SUPPRESSION 8 0.0095
102 CHOLANGIOCARCINOMA 14 0.0094
103 EJECTION FRACTION ABNORMAL 11 0.0090
104 METASTASES TO LIVER 157 0.0089
105 PANCREATIC ENZYMES INCREASED 13 0.0089
106 GLIOBLASTOMA 15 0.0088
107 CONCOMITANT DISEASE AGGRAVATED 54 0.0087
108 LIPASE INCREASED 67 0.0087
109 LYMPHANGIOSIS CARCINOMATOSA 9 0.0086
110 METASTASES TO SPINE 29 0.0086
111 CARDIAC DYSFUNCTION 32 0.0086
112 THERAPY PARTIAL RESPONDER 134 0.0086
113 VITILIGO 20 0.0085
114 RETINAL DETACHMENT 78 0.0085
115 NAIL INFECTION 12 0.0084
116 MALIGNANT PLEURAL EFFUSION 14 0.0083
117 BLOOD LACTATE DEHYDROGENASE INCREASED 131 0.0083
118 SUBRETINAL FLUID 9 0.0082
119 HYPERKERATOSIS 45 0.0081
120 PAPILLARY THYROID CANCER 14 0.0080
121 HYPERTHERMIA 61 0.0080
122 LEFT VENTRICULAR DYSFUNCTION 53 0.0079
123 PERIPHERAL MOTOR NEUROPATHY 11 0.0078
124 BODY TEMPERATURE FLUCTUATION 16 0.0077
125 FEBRILE INFECTION 9 0.0076
126 INGROWING NAIL 18 0.0076
127 ACROCHORDON 10 0.0075
128 SMALL INTESTINAL PERFORATION 14 0.0075
129 NEOPLASM 85 0.0074
130 RETINAL VEIN OCCLUSION 21 0.0073
131 LYMPHOEDEMA 50 0.0072
132 ASPARTATE AMINOTRANSFERASE ABNORMAL 11 0.0072
133 CONCOMITANT DISEASE PROGRESSION 14 0.0072
134 OVARIAN CANCER 64 0.0069
135 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 26 0.0068
136 IMMUNE-MEDIATED ENTEROCOLITIS 25 0.0068
137 DERMATITIS EXFOLIATIVE GENERALISED 23 0.0066
138 SQUAMOUS CELL CARCINOMA 62 0.0066
139 METASTASES TO BONE 108 0.0066
140 CELL DEATH 13 0.0065
141 ADENOVIRUS INFECTION 19 0.0065
142 VENTRICULAR HYPOKINESIA 21 0.0065
143 SARCOIDOSIS 31 0.0065
144 NEUROLOGICAL DECOMPENSATION 15 0.0065
145 NEOPLASM SKIN 10 0.0064
146 PAPILLOEDEMA 29 0.0064
147 THYROID CANCER 76 0.0063
148 LYMPHADENOPATHY MEDIASTINAL 12 0.0063
149 BRAIN NEOPLASM MALIGNANT 28 0.0063
150 HEPATIC LESION 27 0.0062
151 SKIN PAPILLOMA 25 0.0062
152 LYMPHADENITIS 15 0.0062
153 FIBRIN D DIMER INCREASED 22 0.0062
154 RETINAL DISORDER 16 0.0061
155 HYPOALBUMINAEMIA 47 0.0060
156 IMMUNE-MEDIATED LUNG DISEASE 11 0.0060
157 C-REACTIVE PROTEIN INCREASED 219 0.0060
158 SPLEEN DISORDER 10 0.0059
159 CHOLESTATIC LIVER INJURY 13 0.0058
160 ALANINE AMINOTRANSFERASE ABNORMAL 12 0.0057
161 THYROIDITIS 17 0.0057
162 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 13 0.0056
163 HYPERAEMIA 11 0.0056
164 PNEUMONITIS 152 0.0056
165 BODY TEMPERATURE INCREASED 113 0.0055
166 NO THERAPEUTIC RESPONSE 67 0.0055
167 BRAIN OEDEMA 69 0.0055
168 VENTRICULAR DYSFUNCTION 14 0.0054
169 IMPETIGO 8 0.0054
170 LUNG CONSOLIDATION 15 0.0054
171 PIGMENTATION DISORDER 33 0.0053
172 PNEUMATOSIS INTESTINALIS 15 0.0053
173 MELANOCYTIC NAEVUS 23 0.0052
174 VISUAL IMPAIRMENT 645 0.0052
175 HEPATIC CYTOLYSIS 66 0.0052
176 MACULAR OEDEMA 29 0.0052
177 ADRENOCORTICAL INSUFFICIENCY ACUTE 10 0.0051
178 VITREOUS FLOATERS 50 0.0051
179 VITREOUS DETACHMENT 11 0.0051
180 PROTEIN TOTAL DECREASED 19 0.0050
181 CARDIOTOXICITY 45 0.0050
182 BASAL CELL CARCINOMA 78 0.0050
183 HEPATOTOXICITY 111 0.0050
184 BLOOD ALKALINE PHOSPHATASE INCREASED 123 0.0049
185 RASH PUSTULAR 36 0.0049
186 SKIN MASS 33 0.0049
187 ERYTHEMA MULTIFORME 46 0.0049
188 POLYNEUROPATHY 59 0.0049
189 PANCREATIC CARCINOMA METASTATIC 14 0.0049
190 FACIAL PARALYSIS 41 0.0048
191 NEPHRITIS 16 0.0048
192 RASH MACULO-PAPULAR 106 0.0048
193 GAMMA-GLUTAMYLTRANSFERASE INCREASED 105 0.0047
194 GENERAL PHYSICAL CONDITION ABNORMAL 32 0.0047
195 HEPATITIS 120 0.0047
196 BLOOD CHLORIDE DECREASED 12 0.0046
197 PUSTULE 11 0.0046
198 COLORECTAL CANCER METASTATIC 11 0.0046
199 INTESTINAL PERFORATION 52 0.0046
200 FAECES HARD 18 0.0046
201 SERUM FERRITIN INCREASED 24 0.0045
202 CENTRAL NERVOUS SYSTEM LESION 62 0.0045
203 SMALL INTESTINAL HAEMORRHAGE 9 0.0045
204 ADENOCARCINOMA 10 0.0045
205 NEOPLASM RECURRENCE 15 0.0044
206 PRODUCT USE IN UNAPPROVED INDICATION 1091 0.0044
207 FOLLICULITIS 46 0.0044
208 HYPOVOLAEMIC SHOCK 21 0.0044
209 LIVER FUNCTION TEST INCREASED 94 0.0044
210 HOSPICE CARE 43 0.0043
211 MYOSITIS 39 0.0043
212 BODY TEMPERATURE ABNORMAL 8 0.0043
213 SQUAMOUS CELL CARCINOMA OF SKIN 26 0.0043
214 HEPATIC NEOPLASM 14 0.0043
215 BLOOD ALBUMIN DECREASED 34 0.0043
216 ADENOCARCINOMA OF COLON 8 0.0043
217 CHEILITIS 23 0.0042
218 DISEASE PROGRESSION 500 0.0042
219 ASPARTATE AMINOTRANSFERASE INCREASED 222 0.0042
220 GUILLAIN-BARRE SYNDROME 20 0.0041
221 EMBOLISM 34 0.0041
222 DRUG RESISTANCE 105 0.0041
223 EYE OEDEMA 10 0.0041
224 RASH 1764 0.0040
225 GENE MUTATION 8 0.0040
226 SMALL INTESTINE CARCINOMA 9 0.0040
227 LYMPHADENOPATHY 142 0.0040
228 NEOPLASM PROGRESSION 139 0.0040
229 APHTHOUS ULCER 31 0.0040
230 BACTERIAL SEPSIS 13 0.0040
231 BLOOD SODIUM DECREASED 75 0.0040
232 RASH MORBILLIFORM 11 0.0040
233 DEATH 3413 0.0040
234 BRAIN OPERATION 9 0.0039
235 BONE LESION 14 0.0039
236 PHOTOSENSITIVITY REACTION 64 0.0039
237 CHOLESTASIS 74 0.0038
238 PARAPLEGIA 11 0.0038
239 HEPATOCELLULAR INJURY 54 0.0038
240 LUNG OPACITY 10 0.0038
241 MENINGITIS ASEPTIC 17 0.0038
242 DISSEMINATED INTRAVASCULAR COAGULATION 53 0.0038
243 PULMONARY MASS 56 0.0038
244 PRODUCT STORAGE ERROR 328 0.0037
245 MUCOSAL INFLAMMATION 98 0.0037
246 RHABDOMYOLYSIS 155 0.0037
247 CHOLANGITIS 23 0.0037
248 CACHEXIA 19 0.0037
249 RENAL CYST 29 0.0036
250 PERFORMANCE STATUS DECREASED 17 0.0036
251 HEPATIC ENZYME ABNORMAL 18 0.0036
252 RHINOVIRUS INFECTION 14 0.0036
253 INTRACRANIAL PRESSURE INCREASED 20 0.0036
254 DUODENAL ULCER 25 0.0035
255 SKIN LESION 97 0.0035
256 DERMATITIS 74 0.0035
257 BLOOD CREATININE DECREASED 11 0.0035
258 HYDROCEPHALUS 19 0.0035
259 ACNE 263 0.0035
260 NEOPLASM MALIGNANT 231 0.0035
261 LOCALISED OEDEMA 16 0.0035
262 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 80 0.0034
263 CUSHINGOID 11 0.0034
264 STRIDOR 10 0.0034
265 ALANINE AMINOTRANSFERASE INCREASED 207 0.0034
266 ABDOMINAL MASS 9 0.0034
267 INTRA-ABDOMINAL HAEMORRHAGE 8 0.0034
268 COLITIS 126 0.0033
269 MYOCARDITIS 38 0.0033
270 LIP BLISTER 9 0.0033
271 SKIN INFECTION 37 0.0033
272 KERATITIS 10 0.0033
273 ULCERATIVE KERATITIS 9 0.0033
274 TRANSAMINASES INCREASED 73 0.0033
275 ENTERITIS 21 0.0033
276 NODULE 42 0.0032
277 FEELING OF DESPAIR 15 0.0032
278 HYPERNATRAEMIA 16 0.0032
279 INVESTIGATION 10 0.0032
280 TENDERNESS 33 0.0032
281 HYPERREFLEXIA 11 0.0032
282 PYELONEPHRITIS 27 0.0031
283 CEREBRAL DISORDER 23 0.0031
284 ACTINIC KERATOSIS 8 0.0031
285 NIGHT SWEATS 99 0.0031
286 EPIGASTRIC DISCOMFORT 12 0.0031
287 GENERAL PHYSICAL HEALTH DETERIORATION 355 0.0031
288 INCORRECT DOSAGE ADMINISTERED 15 0.0031
289 DEHYDRATION 407 0.0030
290 NEUTROPHIL COUNT INCREASED 31 0.0030
291 ABDOMINAL TENDERNESS 15 0.0030
292 PHOTOPSIA 19 0.0030
293 THROMBOCYTOSIS 11 0.0030
294 HEPATIC FUNCTION ABNORMAL 112 0.0030
295 HYPOPHOSPHATAEMIA 22 0.0030
296 URINE OUTPUT DECREASED 26 0.0030
297 B-CELL LYMPHOMA 10 0.0029
298 CEREBRAL HAEMORRHAGE 105 0.0029
299 MULTIPLE-DRUG RESISTANCE 9 0.0029
300 RED CELL DISTRIBUTION WIDTH INCREASED 12 0.0029
301 TOXIC SKIN ERUPTION 29 0.0029
302 PARTIAL SEIZURES 15 0.0029
303 OEDEMA 154 0.0028
304 REBOUND EFFECT 32 0.0028
305 PULMONARY TOXICITY 20 0.0028
306 TUBULOINTERSTITIAL NEPHRITIS 53 0.0028
307 ESCHERICHIA URINARY TRACT INFECTION 12 0.0028
308 DYSPHAGIA 266 0.0028
309 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 17 0.0028
310 VISION BLURRED 382 0.0028
311 FEEDING DISORDER 56 0.0028
312 STAPHYLOCOCCAL BACTERAEMIA 12 0.0028
313 MONOCYTE COUNT INCREASED 10 0.0028
314 STOMATITIS 167 0.0028
315 ENCEPHALITIS 19 0.0027
316 THERAPY CHANGE 27 0.0027
317 BLEPHARITIS 11 0.0027
318 MAJOR DEPRESSION 20 0.0027
319 AUTOIMMUNE HEPATITIS 19 0.0027
320 GROWTH RETARDATION 8 0.0027
321 SKIN REACTION 38 0.0027
322 HISTIOCYTOSIS HAEMATOPHAGIC 8 0.0027
323 RASH VESICULAR 13 0.0027
324 TONSILLITIS 14 0.0027
325 EATING DISORDER 57 0.0027
326 LYMPHOCYTE COUNT DECREASED 47 0.0027
327 HYPONATRAEMIA 149 0.0026
328 CARDIOMYOPATHY 39 0.0026
329 EMBOLISM VENOUS 8 0.0026
330 ADRENAL INSUFFICIENCY 32 0.0026
331 IRITIS 8 0.0026
332 INFLAMMATORY MARKER INCREASED 13 0.0026
333 ONYCHOCLASIS 18 0.0026
334 BOWEL MOVEMENT IRREGULARITY 20 0.0026
335 DECREASED APPETITE 605 0.0026
336 FUNCTIONAL GASTROINTESTINAL DISORDER 9 0.0026
337 GRANULOMA 9 0.0026
338 AORTIC VALVE INCOMPETENCE 11 0.0026
339 LIVER DISORDER 114 0.0026
340 HYPERAESTHESIA 21 0.0026
341 PAPULE 18 0.0026
342 VENOUS THROMBOSIS 10 0.0025
343 MENINGITIS 17 0.0025
344 PROSTATOMEGALY 10 0.0025
345 TERMINAL STATE 17 0.0025
346 SKIN ABRASION 12 0.0025
347 HEPATIC ENZYME INCREASED 171 0.0025
348 ORAL PAIN 56 0.0025
349 VISUAL FIELD DEFECT 18 0.0025
350 BLOOD PHOSPHORUS DECREASED 9 0.0025
351 LUNG NEOPLASM MALIGNANT 101 0.0025
352 LARGE INTESTINE PERFORATION 17 0.0024
353 STAPHYLOCOCCAL SEPSIS 12 0.0024
354 HYPERTHYROIDISM 35 0.0024
355 PEMPHIGOID 18 0.0024
356 UROSEPSIS 22 0.0024
357 MASS 33 0.0024
358 HEPATIC PAIN 10 0.0023
359 HYPOTHYROIDISM 74 0.0023
360 MYOPATHY 20 0.0023
361 HORDEOLUM 10 0.0023
362 SPLENOMEGALY 27 0.0023
363 CHAPPED LIPS 10 0.0023
364 VOMITING 1083 0.0023
365 HYPERTRANSAMINASAEMIA 16 0.0023
366 PLEURAL EFFUSION 139 0.0023
367 HEMIPLEGIA 19 0.0023
368 MELAENA 50 0.0023
369 GINGIVAL BLEEDING 31 0.0023
370 APHASIA 68 0.0022
371 PANCREATIC DISORDER 11 0.0022
372 PERIPHERAL SENSORY NEUROPATHY 13 0.0022
373 HYPERGLYCAEMIA 81 0.0022
374 SPEECH DISORDER 116 0.0022
375 ASCITES 65 0.0022
376 HEMIPARESIS 37 0.0022
377 BLOOD BILIRUBIN INCREASED 59 0.0022
378 TYPE 1 DIABETES MELLITUS 13 0.0022
379 PANCREATITIS 114 0.0022
380 PNEUMOTHORAX 34 0.0021
381 SEIZURE 246 0.0021
382 PERIPHERAL SWELLING 328 0.0021
383 INTERSTITIAL LUNG DISEASE 103 0.0021
384 LEUKOPENIA 106 0.0021
385 ELECTROCARDIOGRAM QT PROLONGED 76 0.0021
386 DRY SKIN 281 0.0021
387 PROTEINURIA 40 0.0021
388 THERAPY CESSATION 108 0.0021
389 SKIN DISORDER 70 0.0021
390 SEPSIS 234 0.0021
391 EPILEPSY 64 0.0021
392 DRUG ERUPTION 37 0.0021
393 GASTROINTESTINAL TOXICITY 10 0.0021
394 ATRIOVENTRICULAR BLOCK FIRST DEGREE 9 0.0021
395 FACE OEDEMA 35 0.0021
396 NASAL DRYNESS 13 0.0021
397 BONE CANCER 9 0.0021
398 ELECTROLYTE IMBALANCE 24 0.0021
399 LYMPHOPENIA 29 0.0020
400 VISUAL ACUITY REDUCED 68 0.0020
401 RASH GENERALISED 53 0.0020
402 WHITE BLOOD CELL COUNT ABNORMAL 13 0.0020
403 LIVER FUNCTION TEST ABNORMAL 59 0.0020
404 DIARRHOEA 1308 0.0020
405 HYPERCALCAEMIA 25 0.0020
406 ANAL INCONTINENCE 18 0.0020
407 SEPTIC SHOCK 87 0.0020
408 DRUG INTOLERANCE 193 0.0020
409 EYE INFLAMMATION 19 0.0020
410 ALTERED STATE OF CONSCIOUSNESS 43 0.0020
411 ASTHENIA 745 0.0020
412 FATIGUE 1538 0.0020
413 PULMONARY EMBOLISM 187 0.0020
414 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 10 0.0020
415 PRODUCT SUPPLY ISSUE 14 0.0020
416 ISCHAEMIA 9 0.0020
417 PANCREATITIS ACUTE 44 0.0020
418 BLOOD CALCIUM DECREASED 22 0.0020
419 EPISTAXIS 146 0.0019
420 CHROMATURIA 44 0.0019
421 HYPERURICAEMIA 8 0.0019
422 RASH MACULAR 68 0.0019
423 MITRAL VALVE INCOMPETENCE 22 0.0019
424 HAEMORRHAGE INTRACRANIAL 29 0.0019
425 DERMATITIS BULLOUS 14 0.0019
426 THROMBOCYTOPENIA 216 0.0019
427 HEPATIC FAILURE 58 0.0019
428 YELLOW SKIN 9 0.0019
429 PULMONARY HAEMORRHAGE 15 0.0019
430 NAUSEA 1512 0.0019
431 ENTEROCOLITIS 11 0.0019
432 MOUTH ULCERATION 40 0.0019
433 NEPHROTIC SYNDROME 13 0.0019
434 HYPOVOLAEMIA 11 0.0019
435 MULTIPLE ORGAN DYSFUNCTION SYNDROME 53 0.0019
436 NEPHROPATHY TOXIC 21 0.0019
437 EXTRASYSTOLES 13 0.0019
438 PHOTOPHOBIA 35 0.0019
439 PERICARDIAL EFFUSION 43 0.0019
440 BLOOD UREA INCREASED 31 0.0018
441 ILEUS 23 0.0018
442 HAIR COLOUR CHANGES 23 0.0018
443 CYTOKINE RELEASE SYNDROME 37 0.0018
444 CARDIAC FAILURE 148 0.0018
445 INCORRECT PRODUCT STORAGE 24 0.0018
446 VENOOCCLUSIVE LIVER DISEASE 9 0.0018
447 ORGANISING PNEUMONIA 9 0.0018
448 ECZEMA 95 0.0018
449 VIRAL INFECTION 60 0.0018
450 FEELING COLD 50 0.0018
451 OEDEMA PERIPHERAL 218 0.0018
452 HYPOTHERMIA 18 0.0018
453 ILLNESS 183 0.0018
454 TASTE DISORDER 36 0.0018
455 CELLULITIS 89 0.0018
456 PLATELET COUNT INCREASED 23 0.0018
457 INFLAMMATION 91 0.0018
458 TRICUSPID VALVE INCOMPETENCE 14 0.0018
459 BLOOD CREATININE INCREASED 115 0.0018
460 HAEMOPTYSIS 49 0.0018
461 HYPOKALAEMIA 81 0.0018
462 ENDOCARDITIS 9 0.0018
463 CEREBRAL ISCHAEMIA 9 0.0017
464 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 45 0.0017
465 BUNDLE BRANCH BLOCK RIGHT 8 0.0017
466 PULMONARY THROMBOSIS 19 0.0017
467 BLINDNESS 71 0.0017
468 GASTRIC HAEMORRHAGE 20 0.0017
469 MUSCLE STRAIN 15 0.0017
470 MOUTH SWELLING 10 0.0017
471 DECREASED IMMUNE RESPONSIVENESS 17 0.0017
472 HEPATOMEGALY 17 0.0017
473 INFECTION 250 0.0017
474 METABOLIC DISORDER 10 0.0017
475 NEUTROPENIA 233 0.0017
476 GASTROENTERITIS 25 0.0017
477 ANAEMIA 325 0.0017
478 BLINDNESS UNILATERAL 24 0.0017
479 HYPOACUSIS 73 0.0017
480 MYALGIA 288 0.0017
481 OCULAR DISCOMFORT 19 0.0017
482 CONSTIPATION 368 0.0017
483 CHOLECYSTITIS 20 0.0017
484 INTESTINAL OBSTRUCTION 63 0.0017
485 CORONAVIRUS INFECTION 11 0.0017
486 HYPOMAGNESAEMIA 23 0.0017
487 HYPERBILIRUBINAEMIA 17 0.0016
488 INFLUENZA LIKE ILLNESS 135 0.0016
489 ORAL DISORDER 12 0.0016
490 INFLAMMATORY BOWEL DISEASE 16 0.0016
491 ULCER 26 0.0016
492 COLITIS ISCHAEMIC 11 0.0016
493 ULCER HAEMORRHAGE 11 0.0016
494 DRUG-INDUCED LIVER INJURY 51 0.0016
495 SENSORY LOSS 13 0.0016
496 THERAPY INTERRUPTED 115 0.0016
497 DRY MOUTH 130 0.0016
498 HYPOTENSION 321 0.0016
499 NEUTROPHIL COUNT DECREASED 65 0.0016
500 CORONARY ARTERY STENOSIS 8 0.0016
501 CHOLECYSTITIS ACUTE 9 0.0016
502 NEUTROPHILIA 9 0.0016
503 DIPLOPIA 41 0.0016
504 ACUTE KIDNEY INJURY 239 0.0016
505 COAGULOPATHY 26 0.0016
506 OESOPHAGITIS 17 0.0016
507 EYE DISORDER 51 0.0015
508 BENIGN PROSTATIC HYPERPLASIA 8 0.0015
509 ENCEPHALOPATHY 38 0.0015
510 HAEMORRHAGIC STROKE 12 0.0015
511 GENERALISED OEDEMA 19 0.0015
512 ASPERGILLUS INFECTION 10 0.0015
513 CONFUSIONAL STATE 246 0.0015
514 BACTERAEMIA 18 0.0015
515 CLOSTRIDIUM DIFFICILE COLITIS 16 0.0015
516 PANCYTOPENIA 84 0.0015
517 DRY EYE 75 0.0015
518 MALAISE 658 0.0015
519 HAEMATEMESIS 38 0.0015
520 BLOOD POTASSIUM DECREASED 45 0.0015
521 FLANK PAIN 14 0.0015
522 LUNG DISORDER 73 0.0015
523 HAEMATURIA 51 0.0015
524 SYNCOPE 149 0.0015
525 ARTHROPOD BITE 11 0.0015
526 GINGIVITIS 8 0.0015
527 BLOOD CALCIUM INCREASED 13 0.0015
528 MENTAL STATUS CHANGES 41 0.0015
529 LARYNGEAL OEDEMA 9 0.0015
530 CYST 18 0.0014
531 URINARY RETENTION 48 0.0014
532 ATAXIA 17 0.0014
533 LIP DRY 13 0.0014
534 GASTROINTESTINAL HAEMORRHAGE 119 0.0014
535 BLOOD TEST ABNORMAL 20 0.0014
536 STATUS EPILEPTICUS 16 0.0014
537 URINARY TRACT INFECTION 241 0.0014
538 INTERVERTEBRAL DISC DEGENERATION 13 0.0014
539 ELECTROCARDIOGRAM ABNORMAL 11 0.0014
540 NEUROPATHY PERIPHERAL 133 0.0014
541 STEVENS-JOHNSON SYNDROME 31 0.0014
542 CYTOPENIA 17 0.0014
543 ABDOMINAL PAIN 323 0.0014
544 EMPHYSEMA 14 0.0014
545 ATRIAL FIBRILLATION 135 0.0014
546 RASH ERYTHEMATOUS 66 0.0014
547 HYPOCALCAEMIA 26 0.0014
548 RENAL IMPAIRMENT 115 0.0014
549 GROIN PAIN 12 0.0014
550 TUMOUR LYSIS SYNDROME 12 0.0014
551 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 13 0.0014
552 SUPRAVENTRICULAR TACHYCARDIA 13 0.0014
553 SKIN ULCER 35 0.0014
554 ATELECTASIS 13 0.0013
555 ARTHRALGIA 559 0.0013
556 ABNORMAL FAECES 11 0.0013
557 COLON CANCER 20 0.0013
558 MUSCLE ATROPHY 17 0.0013
559 HICCUPS 11 0.0013
560 SINUS TACHYCARDIA 19 0.0013
561 ESCHERICHIA INFECTION 11 0.0013
562 STAPHYLOCOCCAL INFECTION 44 0.0013
563 DYSARTHRIA 50 0.0013
564 INCONTINENCE 14 0.0013
565 GASTRIC ULCER 25 0.0013
566 SCAB 15 0.0013
567 INTERNAL HAEMORRHAGE 15 0.0013
568 PNEUMONIA 425 0.0013
569 COUGH 368 0.0013
570 TREMOR 217 0.0013
571 BLOOD THYROID STIMULATING HORMONE INCREASED 12 0.0013
572 WHITE BLOOD CELL COUNT INCREASED 50 0.0013
573 DYSPNOEA EXERTIONAL 49 0.0013
574 CONJUNCTIVITIS 24 0.0013
575 CIRCULATORY COLLAPSE 22 0.0013
576 HYPOPHAGIA 33 0.0013
577 LUNG INFECTION 20 0.0013
578 BACTERIAL INFECTION 24 0.0013
579 PLATELET COUNT DECREASED 137 0.0013
580 ACUTE MYELOID LEUKAEMIA 20 0.0013
581 PLASMA CELL MYELOMA 50 0.0013
582 SKIN FISSURES 25 0.0013
583 SECRETION DISCHARGE 16 0.0013
584 BLOOD MAGNESIUM DECREASED 11 0.0013
585 ALOPECIA 250 0.0013
586 RENAL FAILURE 169 0.0013
587 GAIT INABILITY 42 0.0013
588 NERVOUS SYSTEM DISORDER 39 0.0012
589 FAECES DISCOLOURED 27 0.0012
590 HAEMOGLOBIN ABNORMAL 8 0.0012
591 THROMBOSIS 100 0.0012
592 SKIN DISCOLOURATION 57 0.0012
593 BLOOD PRESSURE DECREASED 82 0.0012
594 HEADACHE 771 0.0012
595 GASTROINTESTINAL DISORDER 110 0.0012
596 JAUNDICE 33 0.0012
597 PRODUCT USE ISSUE 230 0.0012
598 POLYURIA 10 0.0012
599 OPTIC NEURITIS 11 0.0012
600 HAEMATOCRIT DECREASED 24 0.0012
601 SPINAL COMPRESSION FRACTURE 10 0.0012
602 PHARYNGITIS 15 0.0012
603 SKIN CANCER 26 0.0012
604 APPETITE DISORDER 8 0.0012
605 DECREASED ACTIVITY 13 0.0012
606 RASH PAPULAR 27 0.0012
607 HYDRONEPHROSIS 9 0.0012
608 JOINT SWELLING 145 0.0012
609 PULMONARY FIBROSIS 23 0.0012
610 LIMB DISCOMFORT 37 0.0012
611 BACK INJURY 13 0.0012
612 SPINAL PAIN 14 0.0012
613 WEIGHT DECREASED 333 0.0012
614 PRODUCT AVAILABILITY ISSUE 27 0.0012
615 SKIN PLAQUE 10 0.0012
616 GASTROINTESTINAL PAIN 13 0.0012
617 URINARY INCONTINENCE 35 0.0012
618 GASTRITIS 31 0.0012
619 TACHYPNOEA 16 0.0012
620 DIARRHOEA HAEMORRHAGIC 11 0.0012
621 ARTERIOSCLEROSIS 11 0.0012
622 DIFFUSE LARGE B-CELL LYMPHOMA 9 0.0012
623 HYPERHIDROSIS 150 0.0012
624 SPUTUM DISCOLOURED 11 0.0012
625 HAEMOGLOBIN DECREASED 119 0.0012
626 DELIRIUM 40 0.0012
627 ERYTHEMA 235 0.0011
628 HYPOXIA 40 0.0011
629 FURUNCLE 9 0.0011
630 COLD SWEAT 20 0.0011
631 BLISTER 63 0.0011
632 VASCULITIS 13 0.0011
633 ADVERSE DRUG REACTION 100 0.0011
634 WOUND 31 0.0011
635 SHOCK HAEMORRHAGIC 9 0.0011
636 DECUBITUS ULCER 9 0.0011
637 GASTROINTESTINAL CARCINOMA 10 0.0011
638 BRAIN INJURY 11 0.0011
639 DYSSTASIA 32 0.0011
640 BLOOD IRON DECREASED 13 0.0011
641 MUSCULAR WEAKNESS 124 0.0011
642 PNEUMONIA BACTERIAL 10 0.0011
643 WHITE BLOOD CELL COUNT DECREASED 118 0.0011
644 ILL-DEFINED DISORDER 66 0.0011
645 UPPER RESPIRATORY TRACT INFECTION 50 0.0011
646 TACHYCARDIA 96 0.0011
647 CARDIAC DISORDER 101 0.0011
648 LETHARGY 62 0.0011
649 MALNUTRITION 12 0.0011
650 PULMONARY OEDEMA 48 0.0011
651 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 193 0.0011
652 RASH PRURITIC 58 0.0011
653 KIDNEY INFECTION 21 0.0011
654 RESPIRATORY FAILURE 78 0.0011
655 EYE PAIN 60 0.0011
656 DIABETES MELLITUS 81 0.0011
657 SWELLING FACE 69 0.0011
658 SMALL INTESTINAL OBSTRUCTION 13 0.0011
659 ADVERSE REACTION 14 0.0011
660 ABDOMINAL DISCOMFORT 176 0.0010
661 SPINAL FRACTURE 21 0.0010
662 INCREASED APPETITE 20 0.0010
663 SHOCK 24 0.0010
664 DEVICE RELATED INFECTION 16 0.0010
665 RENAL PAIN 11 0.0010
666 SINUS BRADYCARDIA 10 0.0010
667 DEAFNESS 27 0.0010
668 DYSURIA 38 0.0010
669 FLATULENCE 58 0.0010
670 GASTROINTESTINAL INFLAMMATION 8 0.0010
671 LIP SWELLING 34 0.0010
672 LIVER INJURY 25 0.0010
673 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 9 0.0010
674 PERITONITIS 21 0.0010
675 ARRHYTHMIA 48 0.0010
676 SKIN HAEMORRHAGE 15 0.0010
677 CYSTITIS 32 0.0010
678 ASPIRATION 11 0.0010
679 PANCREATIC CARCINOMA 29 0.0010
680 GASTROINTESTINAL INFECTION 9 0.0010
681 APHONIA 14 0.0010
682 RESPIRATORY TRACT INFECTION 26 0.0010
683 OFF LABEL USE 873 0.0010
684 SWELLING 93 0.0010
685 VENTRICULAR FIBRILLATION 11 0.0010
686 OCULAR HYPERAEMIA 47 0.0010
687 GLAUCOMA 19 0.0010
688 RETCHING 21 0.0010
689 SKIN EXFOLIATION 83 0.0010
690 ASPHYXIA 8 0.0010
691 CARDIOGENIC SHOCK 14 0.0010
692 LOSS OF CONSCIOUSNESS 125 0.0010
693 IRON DEFICIENCY ANAEMIA 9 0.0010
694 PAIN IN EXTREMITY 287 0.0010
695 PRODUCT DISTRIBUTION ISSUE 9 0.0010
696 HEPATIC STEATOSIS 18 0.0010
697 HYPOKINESIA 14 0.0010
698 PETECHIAE 10 0.0010
699 GAIT DISTURBANCE 183 0.0010
700 BLOOD PRESSURE ABNORMAL 19 0.0010
701 FEBRILE NEUTROPENIA 63 0.0009
702 PRESYNCOPE 23 0.0009
703 LOWER RESPIRATORY TRACT INFECTION 43 0.0009
704 RED BLOOD CELL COUNT DECREASED 27 0.0009
705 RENAL DISORDER 44 0.0009
706 HYPERTENSION 200 0.0009
707 ABDOMINAL PAIN UPPER 194 0.0009
708 DYSGEUSIA 70 0.0009
709 AMNESIA 61 0.0009
710 ACUTE RESPIRATORY FAILURE 18 0.0009
711 SCAR 16 0.0009
712 DISORIENTATION 37 0.0009
713 PRURITUS 356 0.0009
714 HAEMATOCHEZIA 51 0.0009
715 PHARYNGEAL SWELLING 9 0.0009
716 BODY TEMPERATURE DECREASED 9 0.0009
717 WOUND INFECTION 10 0.0009
718 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 50 0.0009
719 LOCALISED INFECTION 22 0.0009
720 CATARACT 54 0.0009
721 DYSPHONIA 53 0.0009
722 NOCTURIA 11 0.0009
723 LUNG INFILTRATION 8 0.0009
724 BONE PAIN 53 0.0009
725 DISEASE RECURRENCE 43 0.0009
726 CARDIOMEGALY 11 0.0009
727 PAIN OF SKIN 24 0.0009
728 HAEMORRHAGE 93 0.0009
729 PRODUCT USE COMPLAINT 14 0.0009
730 CANDIDA INFECTION 15 0.0009
731 EYELID PTOSIS 9 0.0009
732 LEUKOCYTOSIS 16 0.0009
733 AGEUSIA 22 0.0009
734 PNEUMONIA ASPIRATION 22 0.0009
735 MYOCARDIAL ISCHAEMIA 10 0.0009
736 SCIATICA 14 0.0009
737 TEMPERATURE INTOLERANCE 9 0.0009
738 CLOSTRIDIUM DIFFICILE INFECTION 19 0.0009
739 DEPRESSED MOOD 46 0.0009
740 DIVERTICULITIS 24 0.0009
741 HOSPITALISATION 133 0.0009
742 FEELING HOT 53 0.0009
743 AGRANULOCYTOSIS 16 0.0009
744 INTRAOCULAR PRESSURE INCREASED 11 0.0009
745 TOXIC EPIDERMAL NECROLYSIS 13 0.0009
746 FEAR 23 0.0009
747 SUDDEN DEATH 9 0.0008
748 ACUTE RESPIRATORY DISTRESS SYNDROME 15 0.0008
749 DYSPNOEA 479 0.0008
750 FULL BLOOD COUNT DECREASED 17 0.0008
751 HAEMATOTOXICITY 8 0.0008
752 THIRST 15 0.0008
753 PAIN 514 0.0008
754 EYE SWELLING 31 0.0008
755 OROPHARYNGEAL PAIN 77 0.0008
756 EYE HAEMORRHAGE 11 0.0008
757 CEREBRAL INFARCTION 20 0.0008
758 DEEP VEIN THROMBOSIS 53 0.0008
759 ABSCESS 13 0.0008
760 GLOMERULAR FILTRATION RATE DECREASED 10 0.0008
761 COGNITIVE DISORDER 38 0.0008
762 HYPERTENSIVE CRISIS 9 0.0008
763 DEPRESSED LEVEL OF CONSCIOUSNESS 32 0.0008
764 THERAPEUTIC RESPONSE DECREASED 49 0.0008
765 MENTAL DISORDER 35 0.0008
766 DISCOMFORT 49 0.0008
767 MUSCLE TIGHTNESS 13 0.0008
768 PERIPHERAL COLDNESS 11 0.0008
769 CARDIAC ARREST 66 0.0008
770 ABDOMINAL PAIN LOWER 20 0.0008
771 BLOOD URINE PRESENT 15 0.0008
772 MICTURITION URGENCY 9 0.0008
773 DRY THROAT 8 0.0008
774 HYPERSENSITIVITY 145 0.0008
775 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 8 0.0008
776 MOVEMENT DISORDER 25 0.0008
777 DIZZINESS 388 0.0008
778 MYELOSUPPRESSION 28 0.0008
779 LYMPHOMA 12 0.0008
780 GASTROENTERITIS VIRAL 14 0.0008
781 DYSPEPSIA 76 0.0008
782 ORAL HERPES 15 0.0008
783 PULMONARY HYPERTENSION 16 0.0008
784 HYPERSOMNIA 22 0.0008
785 BACK PAIN 178 0.0008
786 INCORRECT DOSE ADMINISTERED 174 0.0008
787 RESPIRATORY DISTRESS 21 0.0008
788 IMMUNE SYSTEM DISORDER 10 0.0008
789 PULMONARY CONGESTION 10 0.0008
790 SARS-COV-2 TEST POSITIVE 10 0.0008
791 THERAPY NON-RESPONDER 34 0.0008
792 VERTIGO 46 0.0008
793 BRADYCARDIA 40 0.0008
794 PRODUCTIVE COUGH 36 0.0008
795 MACULAR DEGENERATION 9 0.0008
796 INFLUENZA 84 0.0008
797 SENSORY DISTURBANCE 12 0.0007
798 QUALITY OF LIFE DECREASED 10 0.0007
799 LOCAL SWELLING 13 0.0007
800 MEMORY IMPAIRMENT 102 0.0007
801 HYPERKALAEMIA 26 0.0007
802 NEPHROLITHIASIS 34 0.0007
803 NEURALGIA 18 0.0007
804 HEAD DISCOMFORT 13 0.0007
805 NECK PAIN 41 0.0007
806 OSTEONECROSIS 24 0.0007
807 TOXICITY TO VARIOUS AGENTS 123 0.0007
808 MUSCULOSKELETAL PAIN 38 0.0007
809 CYTOMEGALOVIRUS INFECTION 12 0.0007
810 SKIN IRRITATION 33 0.0007
811 DERMATITIS ALLERGIC 9 0.0007
812 HIP FRACTURE 23 0.0007
813 MUSCULOSKELETAL CHEST PAIN 11 0.0007
814 HYPOAESTHESIA 106 0.0007
815 ERECTILE DYSFUNCTION 18 0.0007
816 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 12 0.0007
817 ARTHRITIS 55 0.0007
818 PARALYSIS 10 0.0007
819 RECTAL HAEMORRHAGE 30 0.0007
820 SOMNOLENCE 140 0.0007
821 NERVOUSNESS 36 0.0007
822 PRODUCT DISPENSING ERROR 15 0.0007
823 FRACTURE 13 0.0007
824 URTICARIA 115 0.0007
825 FALL 228 0.0007
826 NEUROTOXICITY 12 0.0007
827 EOSINOPHILIA 12 0.0007
828 NASOPHARYNGITIS 126 0.0007
829 TOOTH INFECTION 9 0.0007
830 BLOOD POTASSIUM INCREASED 11 0.0007
831 LOWER LIMB FRACTURE 13 0.0007
832 PARAESTHESIA 106 0.0007
833 ABDOMINAL DISTENSION 70 0.0007
834 FREQUENT BOWEL MOVEMENTS 18 0.0007
835 MUSCLE SPASMS 122 0.0007
836 GENERALISED TONIC-CLONIC SEIZURE 11 0.0007
837 HEAD INJURY 21 0.0007
838 OSTEOMYELITIS 12 0.0007
839 BALANCE DISORDER 57 0.0007
840 CEREBROVASCULAR ACCIDENT 110 0.0006
841 FLUID RETENTION 33 0.0006
842 POLLAKIURIA 27 0.0006
843 HUNGER 9 0.0006
844 PRODUCT ADMINISTRATION ERROR 13 0.0006
845 ACCIDENTAL OVERDOSE 23 0.0006
846 PALLOR 17 0.0006
847 TRANSIENT ISCHAEMIC ATTACK 21 0.0006
848 APATHY 9 0.0006
849 HEART RATE INCREASED 61 0.0006
850 CHOKING 12 0.0006
851 TOOTHACHE 11 0.0006
852 CONTUSION 58 0.0006
853 HAIR TEXTURE ABNORMAL 8 0.0006
854 TREATMENT FAILURE 49 0.0006
855 DRUG DISPENSING ERROR 9 0.0006
856 FEELING ABNORMAL 141 0.0006
857 LACTIC ACIDOSIS 19 0.0006
858 ACUTE HEPATIC FAILURE 8 0.0006
859 BURNING SENSATION 41 0.0006
860 THYROID DISORDER 9 0.0006
861 EMOTIONAL DISORDER 18 0.0006
862 RIB FRACTURE 12 0.0006
863 FEMUR FRACTURE 18 0.0006
864 HAEMATOMA 15 0.0006
865 ORTHOSTATIC HYPOTENSION 10 0.0006
866 BLOOD TRIGLYCERIDES INCREASED 10 0.0006
867 HAEMORRHOIDS 11 0.0006
868 DRUG INTERACTION 88 0.0006
869 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 16 0.0005
870 COMA 26 0.0005
871 PRODUCT PRESCRIBING ERROR 13 0.0005
872 ACUTE MYOCARDIAL INFARCTION 16 0.0005
873 BLOOD GLUCOSE ABNORMAL 10 0.0005
874 BLOOD PRESSURE INCREASED 82 0.0005
875 UPPER GASTROINTESTINAL HAEMORRHAGE 9 0.0005
876 RESPIRATORY DISORDER 16 0.0005
877 OXYGEN SATURATION DECREASED 30 0.0005
878 HOT FLUSH 40 0.0005
879 MOBILITY DECREASED 38 0.0005
880 CARDIO-RESPIRATORY ARREST 22 0.0005
881 POST PROCEDURAL COMPLICATION 10 0.0005
882 DRUG INEFFECTIVE 686 0.0005
883 BLOOD GLUCOSE INCREASED 98 0.0005
884 COVID-19 91 0.0005
885 HYPOGLYCAEMIA 25 0.0005
886 LIMB INJURY 14 0.0005
887 DELUSION 8 0.0005
888 LABORATORY TEST ABNORMAL 15 0.0005
889 ISCHAEMIC STROKE 9 0.0005
890 HALLUCINATION 38 0.0005
891 DEMENTIA 14 0.0005
892 LACRIMATION INCREASED 15 0.0005
893 MENTAL IMPAIRMENT 12 0.0005
894 BONE DISORDER 9 0.0005
895 RESTLESSNESS 18 0.0005
896 ANGINA PECTORIS 14 0.0005
897 EAR INFECTION 13 0.0005
898 ABASIA 12 0.0005
899 NASAL CONGESTION 28 0.0005
900 WEIGHT INCREASED 106 0.0005
901 MUSCULOSKELETAL DISORDER 9 0.0005
902 BRONCHITIS 35 0.0005
903 RESPIRATORY ARREST 13 0.0005
904 ERUCTATION 9 0.0005
905 EAR PAIN 9 0.0005
906 CARDIAC FAILURE CONGESTIVE 37 0.0005
907 GASTROOESOPHAGEAL REFLUX DISEASE 37 0.0005
908 IMPAIRED HEALING 15 0.0005
909 SLEEP DISORDER 32 0.0005
910 FUNGAL INFECTION 15 0.0004
911 HEART RATE IRREGULAR 10 0.0004
912 PRODUCT DOSE OMISSION ISSUE 129 0.0004
913 OSTEOPOROSIS 18 0.0004
914 CHEST PAIN 81 0.0004
915 GLYCOSYLATED HAEMOGLOBIN INCREASED 11 0.0004
916 ANAPHYLACTIC REACTION 24 0.0004
917 EYE IRRITATION 25 0.0004
918 INTENTIONAL PRODUCT USE ISSUE 38 0.0004
919 CARDIOVASCULAR DISORDER 11 0.0004
920 HEART RATE DECREASED 15 0.0004
921 PALPITATIONS 50 0.0004
922 CONDITION AGGRAVATED 129 0.0004
923 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 30 0.0004
924 INTENTIONAL DOSE OMISSION 12 0.0004
925 TINNITUS 19 0.0004
926 MYOCARDIAL INFARCTION 72 0.0004
927 INTERVERTEBRAL DISC PROTRUSION 9 0.0004
928 BLOOD PRESSURE SYSTOLIC INCREASED 8 0.0004
929 DEPRESSION 93 0.0004
930 AGITATION 30 0.0004
931 MOOD ALTERED 11 0.0004
932 HERPES ZOSTER 23 0.0004
933 SURGERY 23 0.0004
934 MUSCLE TWITCHING 9 0.0004
935 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 78 0.0004
936 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 20 0.0004
937 DISTURBANCE IN ATTENTION 20 0.0004
938 CHOLELITHIASIS 12 0.0004
939 PROCEDURAL PAIN 10 0.0004
940 COLITIS ULCERATIVE 16 0.0004
941 ANXIETY 100 0.0004
942 INTERNATIONAL NORMALISED RATIO INCREASED 10 0.0004
943 INSOMNIA 93 0.0003
944 EXTRA DOSE ADMINISTERED 14 0.0003
945 MUSCULOSKELETAL STIFFNESS 30 0.0003
946 MIGRAINE 32 0.0003
947 CHEST DISCOMFORT 34 0.0003
948 TYPE 2 DIABETES MELLITUS 11 0.0003
949 ARTHROPATHY 18 0.0003
950 ANGIOEDEMA 14 0.0003
951 SINUSITIS 32 0.0003
952 ANAPHYLACTIC SHOCK 8 0.0003
953 RENAL INJURY 9 0.0003
954 ANGER 10 0.0003
955 FLUSHING 30 0.0003
956 RHINORRHOEA 19 0.0003
957 BLOOD GLUCOSE DECREASED 14 0.0003
958 GASTRIC DISORDER 10 0.0003
959 SWOLLEN TONGUE 9 0.0003
960 VAGINAL HAEMORRHAGE 12 0.0003
961 DEVICE DISLOCATION 12 0.0003
962 ADVERSE EVENT 25 0.0003
963 CORONARY ARTERY DISEASE 8 0.0003
964 BLOOD CHOLESTEROL INCREASED 12 0.0003
965 MULTIPLE SCLEROSIS 12 0.0003
966 CRYING 9 0.0002
967 NO ADVERSE EVENT 44 0.0002
968 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 17 0.0002
969 COLORECTAL CANCER 11 0.0002
970 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 11 0.0002
971 DRUG DOSE OMISSION 37 0.0002
972 SKIN BURNING SENSATION 16 0.0002
973 THERAPEUTIC RESPONSE UNEXPECTED 10 0.0002
974 PRODUCT DOSE OMISSION 14 0.0002
975 THROAT IRRITATION 9 0.0002
976 DYSKINESIA 8 0.0002
977 CONVULSION 11 0.0002
978 WHEEZING 11 0.0002
979 UNEVALUABLE EVENT 14 0.0002
980 PROSTATE CANCER 14 0.0002
981 BREAST CANCER 16 0.0002
982 IRRITABILITY 10 0.0002
983 MEDICATION ERROR 9 0.0002
984 INJURY 11 0.0002
985 OVERDOSE 33 0.0002
986 INTENTIONAL PRODUCT MISUSE 13 0.0001
987 PSORIASIS 19 0.0001
988 RHEUMATOID ARTHRITIS 16 0.0001
989 UNDERDOSE 10 0.0001
990 MULTIPLE SCLEROSIS RELAPSE 9 0.0001
991 CHRONIC KIDNEY DISEASE 9 0.0001
992 EMOTIONAL DISTRESS 9 0.0001
993 ASTHMA 8 0.0001